Macrophage heterogeneity in respiratory diseases

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Boorsma, Carian E ^a,b   Draijer, Christina ^a,b   Melgert, Barbro N ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTAGLANDIN E2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; CELL ACTIVATION; CELL FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; HOMEOSTASIS; HUMAN; LUNG FIBROSIS; MACROPHAGE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; UPREGULATION; IMMUNOLOGY;

ASTHMA; HUMANS; MACROPHAGES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS;

EID: 84875670440     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/769214     Document Type: Review

References (228)

1. Stefater J. A. III, Ren S., Lang R. A., Duffield J. S., Metchnikoff's policemen: macrophages in development, homeostasis and regeneration. Trends in Molecular Medicine 2011 17 12 743 752 10.1016/j.molmed.2011.07.009
2. Gordon S., The macrophage: past, present and future. European Journal of Immunology 2007 37 1 S9 S17 2-s2.0-36249032544 10.1002/eji.200737638 (Pubitemid 350131264)
3. Gordon S., Taylor P. R., Monocyte and macrophage heterogeneity. Nature Reviews Immunology 2005 5 12 953 964 2-s2.0-28544446111 10.1038/nri1733 (Pubitemid 41746764)
4. Martinez F. O., Sica A., Mantovani A., Locati M., Macrophage activation and polarization. Frontiers in Bioscience 2008 13 2 453 461 2-s2.0-38449102676 10.2741/2692 (Pubitemid 351599757)
5. Mosser D. M., Edwards J. P., Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 2008 8 12 958 969 2-s2.0-56749174940 10.1038/nri2448
6. Geissmann F., Gordon S., Hume D. A., Mowat A. M., Randolph G. J., Unravelling mononuclear phagocyte heterogeneity. Nature Reviews Immunology 2010 10 6 453 460 2-s2.0-77952887297 10.1038/nri2784
7. Schneberger D., Aharonson-Raz K., Singh B., Monocyte and macrophage heterogeneity and Toll-like receptors in the lung. Cell and Tissue Research 2011 343 1 97 106 2-s2.0-79151473459 10.1007/s00441-010-1032-2
8. Franke-Ullmann G., Pförtner C., Walter P., Steinmüller C., Lohmann-Matthes M. L., Kobzik L., Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro. The Journal of Immunology 1996 157 7 3097 3104 2-s2.0-0030266774 (Pubitemid 126450070)
9. Bedoret D., Wallemacq H., Marichal T., Desmet C., Calvo F. Q., Henry E., Closset R., Dewals B., Thielen C., Gustin P., De Leval L., Van Rooijen N., Le Moine A., Vanderplasschen A., Cataldo D., Drion P. V., Moser M., Lekeux P., Bureau F., Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. Journal of Clinical Investigation 2009 119 12 3723 3738 2-s2.0-72849113090 10.1172/JCI39717
10. Prokhorova S., Lavrikova N., Laskin D. L., Functional characterization of interstitial macrophages and subpopulations of alveolar macrophages from rat lung. Journal of Leukocyte Biology 1994 55 2 141 146 2-s2.0-0028055232 (Pubitemid 24066334)
11. Landsman L., Varol C., Jung S., Distinct differentiation potential of blood monocyte subsets in the lung. The Journal of Immunology 2007 178 4 2000 2007 2-s2.0-33846414364 (Pubitemid 46233396)
12. Krausgruber T., Blazek K., Smallie T., Alzabin S., Lockstone H., Sahgal N., Hussell T., Feldmann M., Udalova I. A., IRF5 promotes inflammatory macrophage polarization and T H1-TH17 responses. Nature Immunology 2011 12 3 231 238 2-s2.0-79951671510 10.1038/ni.1990
13. Biswas S. K., Mantovani A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature Immunology 2010 11 10 889 896 2-s2.0-77956976681 10.1038/ni.1937
14. Wirth J. J., Kierszenbaum F., Sonnenfeld G., Zlotnik A., Enhancing effects of gamma interferon on phagocytic cell association with and killing of Trypanosoma cruzi. Infection and Immunity 1985 49 1 61 66 2-s2.0-0021885239 (Pubitemid 15062869)
15. Higginbotham J. N., Lin T. L., Pruett S. B., Effect of macrophage activation on killing of Listeria monocytogenes. Roles of reactive oxygen or nitrogen intermediates, rate of phagocytosis, and retention of bacteria in endosomes. Clinical and Experimental Immunology 1992 88 3 492 498 2-s2.0-0026755245
16. Song E., Ouyang N., Hörbelt M., Antus B., Wang M., Exton M. S., Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cellular Immunology 2000 204 1 19 28 2-s2.0-0033779575 10.1006/cimm.2000.1687
17. Hanania R., Song Sun H., Xu K., Pustylnik S., Jeganathan S., Harrison R. E., Classically activated macrophages use stable microtubules for matrix metalloproteinase-9 (MMP-9) secretion. The Journal of Biological Chemistry 2012 287 11 8468 8483 10.1074/jbc.M111.290676
18. Gordon S., Alternative activation of macrophages. Nature Reviews Immunology 2003 3 1 23 35 (Pubitemid 37328697)
19. Stein M., Keshav S., Harris N., Gordon S., Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. Journal of Experimental Medicine 1992 176 1 287 292 2-s2.0-0026762988 10.1084/jem.176.1.287
20. Sica A., Mantovani A., Macrophage plasticity and polarization: in vivo veritas. Journal of Clinical Investigation 2012 122 3 787 795 10.1172/JCI59643
21. Satoh T., Takeuchi O., Vandenbon A., Yasuda K., Tanaka Y., Kumagai Y., Miyake T., Matsushita K., Okazaki T., Saitoh T., Honma K., Matsuyama T., Yui K., Tsujimura T., Standley D. M., Nakanishi K., Nakai K., Akira S., The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature Immunology 2010 11 10 936 944 2-s2.0-77956954197 10.1038/ni.1920
22. Martinez F. O., Helming L., Gordon S., Alternative activation of macrophages: an immunologic functional perspective. Annual Review of Immunology 2009 27 451 483 2-s2.0-67650485985 10.1146/annurev.immunol.021908.132532
23. Martinez F. O., Helming L., Milde R., Varin A., Melgert B. N., Draijer C., Thomas B., Fabbri M., Crawshaw A., Ho L. P., Hacken ten N. H., Cobos Jimenez V., Kootstra N. A., Hamann J., Greaves D. R., Locati M., Mantovani A., Gordon S., Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood 2013 10.1182/blood-2012-06-436212
24. Kreider T., Anthony R. M., Urban J. F., Gause W. C., Alternatively activated macrophages in helminth infections. Current Opinion in Immunology 2007 19 4 448 453 2-s2.0-34548129526 10.1016/j.coi.2007.07.002 (Pubitemid 47299196)
25. Nair M. G., Cochrane D. W., Allen J. E., Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro. Immunology Letters 2003 85 2 173 180 2-s2.0-0037460123 10.1016/S0165-2478(02)00225-0 (Pubitemid 36071573)
26. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A., Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology 2002 23 11 549 555 2-s2.0-0036839143 10.1016/S1471-4906(02)02302-5 (Pubitemid 35223554)
27. Madsen D. H., Ingvarsen S., Jürgensen H. J., Melander M. C., Kjøller L., Moyer A., Honoré C., Madsen C. A., Garred P., Burgdorf S., Bugge T. H., Behrendt N., Engelholm L. H., The non-phagocytic route of collagen uptake: a distinct degradation pathway. The Journal of Biological Chemistry 2011 286 30 26996 27010 10.1074/jbc.M110.208033
28. Cairo G., Recalcati S., Mantovani A., Locati M., Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends in Immunology 2011 32 6 241 247 2-s2.0-79957723868 10.1016/j.it.2011.03.007
29. Almeida C. A. M., Roberts S. G., Laird R., McKinnon E., Ahmed I., Pfafferott K., Turley J., Keane N. M., Lucas A., Rushton B., Chopra A., Mallal S., John M., Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses. Journal of Immunological Methods 2009 344 1 1 5 2-s2.0-65049088939 10.1016/j.jim.2009.02.007
30. + monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 2009 50 1 261 274 2-s2.0-67651174837 10.1002/hep.22950
31. Schmid-Kotsas A., Gross H. J., Menke A., Weidenbach H., Adler G., Siech M., Beger H., Grünert A., Bachem M. G., Lipopolysaccharide-activated macrophages stimulate the synthesis of collagen type I and C-fibronectin in cultured pancreatic stellate cells. American Journal of Pathology 1999 155 5 1749 1758 2-s2.0-0032704154
32. Xing Z., Tremblay G. M., Sime P. J., Gauldie J., Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor- β 1 and myofibroblast accumulation. American Journal of Pathology 1997 150 1 59 66 2-s2.0-0031022618 (Pubitemid 27027096)
33. Lawrence T., Natoli G., Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nature 2011 11 11 750 761 10.1038/nri3088
34. Holgate S. T., Pathogenesis of asthma. Clinical & Experimental Allergy 2008 38 6 872 897 2-s2.0-47949119866 10.1111/j.1365-2222.2008.02971.x
35. Wenzel S., Severe asthma in adults. American Journal of Respiratory and Critical Care Medicine 2005 172 2 149 160 2-s2.0-22144452574 10.1164/rccm.200409-1181PP (Pubitemid 40981187)
36. Anderson G. P., Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. The Lancet 2008 372 9643 1107 1119 2-s2.0-52049087356 10.1016/S0140-6736(08)61452-X
37. Hammad H., Lambrecht B. N., Dendritic cells and airway epithelial cells at the interface between innate and adaptive immune responses. Allergy 2011 66 5 579 587 2-s2.0-79953756066 10.1111/j.1398-9995.2010.02528.x
38. Peters-Golden M., The alveolar macrophage: the forgotten cell in asthma. American Journal of Respiratory Cell and Molecular Biology 2004 31 1 3 7 2-s2.0-3042838551 10.1165/rcmb.f279 (Pubitemid 38888032)
39. Draijer C., Robbe P., Boorsma C. E., Hylkema M. N., Melgert B. N., Characterization of macrophage phenotypes in three murine models of house dust mite-induced asthma. Mediators of Inflammation 2013 2013 10.1155/2013/632049
40. Kim Y. K., Oh S. Y., Jeon S. G., Park H. W., Lee S. Y., Chun E. Y., Bang B., Lee H. S., Oh M. H., Kim Y. S., Kim J. H., Gho Y. S., Cho S. H., Min K. U., Kim Y. Y., Zhu Z., Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. The Journal of Immunology 2007 178 8 5375 5382 2-s2.0-34247135082 (Pubitemid 46595324)
41. Shannon J., Ernst P., Yamauchi Y., Olivenstein R., Lemiere C., Foley S., Cicora L., Ludwig M., Hamid Q., Martin J. G., Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008 133 2 420 426 2-s2.0-39449123817 10.1378/chest.07-1881 (Pubitemid 351272400)
42. Berry M. A., Hargadon B., Shelley M., Parker D., Shaw D. E., Green R. H., Bradding P., Brightling C. E., Wardlaw A. J., Pavord I. D., Evidence of a role of tumor necrosis factor α in refractory asthma. The New England Journal of Medicine 2006 354 7 697 708 2-s2.0-32644490529 10.1056/NEJMoa050580 (Pubitemid 43247140)
43. ten Hacken N. H. T., Timens W., Smith M., Drok G., Kraan J., Postma D. S., Increased peak expiratory flow variation in asthma: severe persistent increase but not nocturnal worsening of airway inflammation. European Respiratory Journal 1998 12 3 546 550 2-s2.0-0031663259 10.1183/09031936.98. 12030546 (Pubitemid 28420129)
44. Heaton T., Rowe J., Turner S., Aalberse R. C., De Klerk N., Suriyaarachchi D., Serralha M., Holt B. J., Hollams E., Yerkovich S., Holt K., Sly P. D., Goldblatt J., Souef P. L., Holt P. G., An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. The Lancet 2005 365 9454 142 149 2-s2.0-19944427405 10.1016/S0140-6736(05)17704-6 (Pubitemid 40091804)
45. Hayashi N., Yoshimoto T., Izuhara K., Matsui K., Tanaka T., Nakanishi K., T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN- γ and IL-13 production. Proceedings of the National Academy of Sciences of the United States of America 2007 104 37 14765 14770 2-s2.0-35548946223 10.1073/pnas.0706378104 (Pubitemid 350003217)
46. Yang M., Kumar R. K., Foster P. S., Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN- γ and TLR4/MyD88 pathways. The Journal of Immunology 2009 182 8 5107 5115 2-s2.0-65249179610 10.4049/jimmunol.0803468
47. Thomas P. S., Heywood G., Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax 2002 57 9 774 778 2-s2.0-0036727009 10.1136/thorax.57.9.774 (Pubitemid 34984975)
48. Lukacs N. W., Strieter R. M., Chensue S. W., Widmer M., Kunkel S. L., TNF- α mediates recruitment of neutrophils and eosinophils during airway inflammation. The Journal of Immunology 1995 154 10 5411 5417 2-s2.0-0028989599
49. Michel O., Kips J., Duchateau J., Vertongen F., Robert L., Collet H., Pauwels R., Sergysels R., Severity of asthma is related to endotoxin in house dust. American Journal of Respiratory and Critical Care Medicine 1996 154 6 1641 1646 2-s2.0-0030451097 (Pubitemid 26424928)
50. Thorne P. S., Kulhánková K., Yin M., Cohn R., Arbes S. J., Zeldin D. C., Endotoxin exposure is a risk factor for asthma: the national survey of endotoxin in United States housing. American Journal of Respiratory and Critical Care Medicine 2005 172 11 1371 1377 2-s2.0-30344449466 10.1164/rccm.200505-758OC (Pubitemid 43069809)
51. Michel O., Duchateau J., Sergysels R., Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. Journal of Applied Physiology 1989 66 3 1059 1064 2-s2.0-0024542885 (Pubitemid 19091329)
52. Rylander R., Bake B., Fischer J. J., Helander I. M., Pulmonary function and symptoms after inhalation of endotoxin. American Review of Respiratory Disease 1989 140 4 981 986 2-s2.0-0024460475 (Pubitemid 19259499)
53. Wang C., Rose-Zerilli M. J., Koppelman G. H., Sandling J. K., Holloway J. W., Postma D. S., Holgate S. T., Bours V., Syvänen A.-C., Dideberg V., Evidence of association between interferon regulatory factor 5 gene polymorphisms and asthma. Gene 2012 504 2 220 225 10.1016/j.gene.2012.05.021
54. Kamath A. V., Pavord I. D., Ruparelia P. R., Chilvers E. R., Is the neutrophil the key effector cell in severe asthma? Thorax 2005 60 7 529 530 2-s2.0-22044440611 10.1136/thx.2005.043182 (Pubitemid 40966203)
55. Goleva E., Hauk P. J., Hall C. F., Liu A. H., Riches D. W. H., Martin R. J., Leung D. Y. M., Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. Journal of Allergy and Clinical Immunology 2008 122 3 550 e3 2-s2.0-50649101494 10.1016/j.jaci.2008.07.007
56. Korf J. E., Pynaert G., Tournoy K., Boonefaes T., Van Oosterhout A., Ginneberge D., Haegeman A., Verschoor J. A., De Baetselier P., Grooten J., Macrophage reprogramming by mycolic acid promotes a tolerogenic response in experimental asthma. American Journal of Respiratory and Critical Care Medicine 2006 174 2 152 160 2-s2.0-33745761198 10.1164/rccm.200507-1175OC (Pubitemid 44015388)
57. Tang C., Inman M. D., Van Rooijen N., Yang P., Shen H., Matsumoto K., O'Byrne P. M., Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN- γ -dependent mechanism. The Journal of Immunology 2001 166 3 1471 1481 2-s2.0-0035253346 (Pubitemid 32114625)
58. Holt P. G., Oliver J., Bilyk N., McMenamin C., McMenamin P. G., Kraal G., Thepen T., Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. Journal of Experimental Medicine 1993 177 2 397 407 2-s2.0-0027461765 (Pubitemid 23117089)
59. Meyts I., Hellings P. W., Hens G., Vanaudenaerde B. M., Verbinnen B., Heremans H., Matthys P., Bullens D. M., Overbergh L., Mathieu C., De Boeck K., Ceuppens J. L., IL-12 contributes to allergen-induced airway inflammation in experimental asthma. The Journal of Immunology 2006 177 9 6460 6470 2-s2.0-33750367858 (Pubitemid 44628865)
60. Chupp G. L., Lee C. G., Jarjour N., Shim Y. M., Holm C. T., He S., Dziura J. D., Reed J., Coyle A. J., Kiener P., Cullen M., Grandsaigne M., Dombret M. C., Aubier M., Pretolani M., Elias J. A., A chitinase-like protein in the lung and circulation of patients with severe asthma. The New England Journal of Medicine 2007 357 20 2016 2027 2-s2.0-36148981436 10.1056/NEJMoa073600 (Pubitemid 350106709)
61. Zhu Z., Zheng T., Homer R. J., Kim Y. K., Chen N. Y., Cohn L., Hamid Q., Elias J. A., Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004 304 5677 1678 1682 2-s2.0-2942668626 10.1126/science.1095336 (Pubitemid 38765861)
62. Melgert B. N., Ten Hacken N. H., Rutgers B., Timens W., Postma D. S., Hylkema M. N., More alternative activation of macrophages in lungs of asthmatic patients. Journal of Allergy and Clinical Immunology 2011 127 3 831 833 2-s2.0-79952316010 10.1016/j.jaci.2010.10.045
63. Kim E. Y., Battaile J. T., Patel A. C., You Y., Agapov E., Grayson M. H., Benoit L. A., Byers D. E., Alevy Y., Tucker J., Swanson S., Tidwell R., Tyner J. W., Morton J. D., Castro M., Polineni D., Patterson G. A., Schwendener R. A., Allard J. D., Peltz G., Holtzman M. J., Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nature Medicine 2008 14 6 633 640 2-s2.0-44949257271 10.1038/nm1770 (Pubitemid 351809546)
64. Subrata L. S., Bizzintino J., Mamessier E., Bosco A., McKenna K. L., Wikström M. E., Goldblatt J., Sly P. D., Hales B. J., Thomas W. R., Laing I. A., LeSouëf P. N., Holt P. G., Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. The Journal of Immunology 2009 183 4 2793 2800 2-s2.0-70149089062 10.4049/jimmunol.0900695
65. Melgert B. N., Oriss T. B., Qi Z., Dixon-McCarthy B., Geerlings M., Hylkema M. N., Ray A., Macrophages: regulators of sex differences in asthma? American Journal of Respiratory Cell and Molecular Biology 2010 42 5 595 603 2-s2.0-77951634926 10.1165/rcmb.2009-0016OC
66. + macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation. BMC Immunology 2012 13 6 10.1186/1471-2172-13-6
67. Moreira A. P., Cavassani K. A., Hullinger R., Rosada R. S., Fong D. J., Murray L., Hesson D. P., Hogaboam C. M., Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease. Journal of Allergy and Clinical Immunology 2010 126 4 712 e7 2-s2.0-77957815198 10.1016/j.jaci.2010.06.010
68. Kim D. Y., Park B. S., Hong G. U., Lee B. J., Park J. W., Kim S. Y., Ro J. Y., Anti-inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin. British Journal of Pharmacology 2011 162 1 210 225 2-s2.0-78650131556 10.1111/j.1476-5381.2010.01033.x
69. Zuberi R. I., Hsu D. K., Kalayci O., Chen H. Y., Sheldon H. K., Yu L., Apgar J. R., Kawakami T., Lilly C. M., Liu F. T., Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. American Journal of Pathology 2004 165 6 2045 2053 2-s2.0-9644275601 (Pubitemid 39578382)
70. Maarsingh H., Zuidhof A. B., Bos I. S. T., Van Duin M., Boucher J. L., Zaagsma J., Meurs H., Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. American Journal of Respiratory and Critical Care Medicine 2008 178 6 565 573 2-s2.0-51849107399 10.1164/rccm.200710-1588OC
71. Nieuwenhuizen N. E., Kirstein F., Jayakumar J., Emedi B., Hurdayal R., Horsnell W. G. C., Lopata A. L., Brombacher F., Allergic airway disease is unaffected by the absence of IL-4R α -dependent alternatively activated macrophages. Journal of Allergy and Clinical Immunology 2012 130 3 743 750 10.1016/j.jaci.2012.03.011
72. Maneechotesuwan K., Supawita S., Kasetsinsombat K., Wongkajornsilp A., Barnes P. J., Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids. Journal of Allergy and Clinical Immunology 2008 121 1 43 50 2-s2.0-38149085198 10.1016/j.jaci.2007.10. 011
73. Fitzpatrick A. M., Higgins M., Holguin F., Brown L. A. S., Teague W. G., The molecular phenotype of severe asthma in children. Journal of Allergy and Clinical Immunology 2010 125 4 851 e18 2-s2.0-77950215411 10.1016/j.jaci.2010. 01.048
74. Ogawa Y., Duru E. A., Ameredes B. T., Role of IL-10 in the resolution of airway inflammation. Current Molecular Medicine 2008 8 5 437 445 2-s2.0-53849116091 10.2174/156652408785160907
75. Vissers J. L. M., van Esch B. C. A. M., Jeurink P. V., Hofman G. A., van Oosterhout A. J. M., Stimulation of allergen-loaded macrophages by TLR9-ligand potentiates IL-10-mediated suppression of allergic airway inflammation in mice. Respiratory Research 2004 5 2-s2.0-17244365364 10.1186/1465-9921-5-21 (Pubitemid 41358075)
76. Mathers C. D., Loncar D., Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 2006 3 11 2011 2030 e442 2-s2.0-33845338724 10.1371/journal.pmed.0030442 (Pubitemid 44875937)
77. Rabe K. F., Hurd S., Anzueto A., Barnes P. J., Buist S. A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., Van Weel C., Zielinski J., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2007 176 6 532 555 2-s2.0-34548660457 10.1164/rccm.200703-456SO (Pubitemid 47403272)
78. McDonough J. E., Yuan R., Suzuki M., Seyednejad N., Elliott W. M., Sanchez P. G., Wright A. C., Gefter W. B., Litzky L., Coxson H. O., Paré P. D., Sin D. D., Pierce R. A., Woods J. C., McWilliams A. M., Mayo J. R., Lam S. C., Cooper J. D., Hogg J. C., Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. The New England Journal of Medicine 2011 365 17 1567 1575 10.1056/NEJMoa1106955
79. Hogg J. C., Timens W., The pathology of chronic obstructive pulmonary disease. Annual Review of Pathology 2009 4 435 459 2-s2.0-66149093072 10.1146/annurev.pathol.4.110807.092145
80. Jackson A. D., Airway goblet-cell mucus secretion. Trends in Pharmacological Sciences 2001 22 1 39 45 2-s2.0-0035153026 10.1016/S0165- 6147(00)01600-X (Pubitemid 32126285)
81. Fraig M., Shreesha U., Savici D., Katzenstein A. L. A., Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. American Journal of Surgical Pathology 2002 26 5 647 653 2-s2.0-0036224683 10.1097/00000478-200205000-00011 (Pubitemid 34438725)
82. Demedts I. K., Bracke K. R., Van Pottelberge G., Testelmans D., Verleden G. M., Vermassen F. E., Joos G. F., Brusselle G. G., Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2007 175 10 998 1005 2-s2.0-34248371233 10.1164/rccm.200608-1113OC (Pubitemid 46741751)
83. Decramer M., Janssens W., Miravitlles M., Chronic obstructive pulmonary disease. The Lancet 2012 379 9823 1341 1351 10.1016/S0140-6736(11)60968-9
84. Brusselle G. G., Joos G. F., Bracke K. R., New insights into the immunology of chronic obstructive pulmonary disease. The Lancet 2011 378 9795 1015 1026 10.1016/S0140-6736(11)60988-4
85. Siafakas N. M., Vermeire P., Pride N. B., Paoletti P., Gibson J., Howard P., Yernault J. C., Decramer M., Higenbottam T., Postma D. S., Rees J., Optimal assessment and management of chronic obstructive pulmonary disease (COPD). European Respiratory Journal 1995 8 8 1398 1420 2-s2.0-0029156848 10.1183/09031936.95.08081398
86. Saetta M., Turato G., Facchini F. M., Corbino L., Lucchini R. E., Casoni G., Maestrelli P., Mapp C. E., Ciaccia A., Fabbri L. M., Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. American Journal of Respiratory and Critical Care Medicine 1997 156 5 1633 1639 2-s2.0-9844225600 (Pubitemid 27505536)
87. O'Donnell R., Breen D., Wilson S., Djukanovic R., Inflammatory cells in the airways in COPD. Thorax 2006 61 5 448 454 2-s2.0-33646554531 10.1136/thx.2004.024463 (Pubitemid 43723331)
88. Finkelstein R., Fraser R. S., Ghezzo H., Cosio M. G., Alveolar inflammation and its relation to emphysema in smokers. American Journal of Respiratory and Critical Care Medicine 1995 152 5 1666 1672 2-s2.0-0028862401 (Pubitemid 3002087)
89. Ofulue A. F., Ko M., Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. American Journal of Physiology 1999 277 1 L97 L105 2-s2.0-0032790739 (Pubitemid 29356755)
90. Hautamaki R. D., Kobayashi D. K., Senior R. M., Shapiro S. D., Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997 277 5334 2002 2004 2-s2.0-0030823772 10.1126/science.277. 5334.2002 (Pubitemid 27449144)
91. Le Quément C., Guénon I., Gillon J. Y., Valença S., Cayron-Elizondo V., Lagente V., Boichot E., The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke. British Journal of Pharmacology 2008 154 6 1206 1215 2-s2.0-47249112549 10.1038/bjp.2008.180 (Pubitemid 351992055)
92. Shaykhiev R., Krause A., Salit J., Strulovici-Barel Y., Harvey B. G., O'Connor T. P., Crystal R. G., Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. The Journal of Immunology 2009 183 4 2867 2883 2-s2.0-70149110900 10.4049/jimmunol.0900473
93. Hodge S., Matthews G., Mukaro V., Ahern J., Shivam A., Hodge G., Holmes M., Jersmann H., Reynolds P. N., Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine. American Journal of Respiratory Cell and Molecular Biology 2011 44 5 673 681 2-s2.0-79955486468 10.1165/rcmb.2009-0459OC
94. Stedman R. L., The chemical composition of tobacco and tobacco smoke. Chemical Reviews 1968 68 2 153 207 2-s2.0-0014277628
95. Ichinose M., Sugiura H., Yamagata S., Koarai A., Shirato K., Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. American Journal of Respiratory and Critical Care Medicine 2000 162 2 701 706 2-s2.0-0033841255 (Pubitemid 30647222)
96. van Straaten J. F. M., Postma D. S., Coers W., Noordhoek J. A., Kauffman H. F., Timens W., Macrophages in lung tissue from patients with pulmonary emphysema express both inducible and endothelial nitric oxide synthase. Modern Pathology 1998 11 7 648 655 2-s2.0-0031866159 (Pubitemid 28335143)
97. Maestrelli P., Páska C., Saetta M., Turato G., Nowicki Y., Monti S., Formichi B., Miniati M., Fabbri L. M., Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. European Respiratory Journal 2003 21 6 971 976 2-s2.0-0037975679 (Pubitemid 36675612)
98. Ito K., Barnes P. J., COPD as a disease of accelerated lung aging. Chest 2009 135 1 173 180 2-s2.0-58249099942 10.1378/chest.08-1419
99. Paredi P., Kharitonov S. A., Leak D., Ward S., Cramer D., Barnes P. J., Exhaled ethane, a marker of lipid peroxidation, is elevated chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2000 162 2 369 373 2-s2.0-0033837472 (Pubitemid 30647168)
100. Montuschi P., Collins J. V., Ciabattoni G., Lazzeri N., Corradi M., Kharitonov S. A., Barnes P. J., Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. American Journal of Respiratory and Critical Care Medicine 2000 162 3 1175 1177 2-s2.0-0033833221
101. Rahman I., Van Schadewijk A. A. M., Crowther A. J. L., Hiemstra P. S., Stolk J., MacNee W., De Boer W. I., 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2002 166 4 490 495 2-s2.0-0037102347 10.1164/rccm.2110101
102. Doz E., Noulin N., Boichot E., Guénon I., Fick L., Le Bert M., Lagente V., Ryffel B., Schnyder B., Quesniaux V. F. J., Couillin I., Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. The Journal of Immunology 2008 180 2 1169 1178 2-s2.0-40449118020
103. Facchinetti F., Amadei F., Geppetti P., Tarantini F., Di Serio C., Dragotto A., Gigli P. M., Catinella S., Civelli M., Patacchini R., α β -unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. American Journal of Respiratory Cell and Molecular Biology 2007 37 5 617 623 2-s2.0-35848940292 10.1165/rcmb.2007-0130OC (Pubitemid 350058193)
104. Demirjian L., Abboud R. T., Li H., Duronio V., Acute effect of cigarette smoke on TNF- α release by macrophages mediated through the erk1/2 pathway. Biochimica et Biophysica Acta 2006 1762 6 592 597 2-s2.0-33745161926 10.1016/j.bbadis.2006.04.004 (Pubitemid 43903122)
105. Walters M. J., Paul-Clark M. J., McMaster S. K., Ito K., Adcock I. M., Mitchell J. A., Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: implications for steroid resistance. Molecular Pharmacology 2005 68 5 1343 1353 2-s2.0-27544494856 10.1124/mol.105.012591 (Pubitemid 41539990)
106. Yang S. R., Chida A. S., Bauter M. R., Shafiq N., Seweryniak K., Maggirwar S. B., Kilty I., Rahman I., Cigarette smoke induces proinflammatory cytokine release by activation of NF- B and posttranslational modifications of histone deacetylase in macrophages. American Journal of Physiology 2006 291 1 L46 L57 2-s2.0-33745728358 10.1152/ajplung.00241.2005
107. Karimi K., Sarir H., Mortaz E., Smit J. J., Hosseini H., De Kimpe S. J., Nijkamp F. P., Folkerts G., Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respiratory Research 2006 7, article 66 2-s2.0-33745483812 10.1186/1465-9921-7-66 (Pubitemid 43959888)
108. Sapey E., Ahmad A., Bayley D., Newbold P., Snell N., Rugman P., Stockley R. A., Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD. Journal of Clinical Immunology 2009 29 4 508 516 2-s2.0-67651244671 10.1007/s10875-009-9286-8
109. Man S. F. P., Connett J. E., Anthonisen N. R., Wise R. A., Tashkin D. P., Sin D. D., C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006 61 10 849 853 2-s2.0-33749998694 10.1136/thx.2006.059808 (Pubitemid 44570304)
110. Bhowmik A., Seemungal T. A. R., Sapsford R. J., Wedzicha J. A., Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000 55 2 114 120 2-s2.0-0034018102 10.1136/thorax.55.2. 114 (Pubitemid 30245950)
111. Bucchioni E., Kharitonov S. A., Allegra L., Barnes P. J., High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respiratory Medicine 2003 97 12 1299 1302 2-s2.0-0346901131 10.1016/j.rmed.2003. 07.008 (Pubitemid 37526998)
112. Yamamoto C., Yoneda T., Yoshikawa M., Fu A., Tokuyama T., Tsukaguchi K., Narita N., Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997 112 2 505 510 2-s2.0-0030788052 (Pubitemid 27349446)
113. Crooks S. W., Bayley D. L., Hill S. L., Stockley R. A., Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. European Respiratory Journal 2000 15 2 274 280 2-s2.0-0033951642 10.1034/j.1399-3003.2000.15b09.x (Pubitemid 30085952)
114. Gompertz S., O'Brien C., Bayley D. L., Hill S. L., Stockley R. A., Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. European Respiratory Journal 2001 17 6 1112 1119 2-s2.0-0034883814 10.1183/09031936.01.99114901 (Pubitemid 32717466)
115. Di Francia M., Barbier D., Mege J. L., Orehek J., Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1994 150 5 1453 1455 2-s2.0-0027996304 (Pubitemid 24356667)
116. Keatings V. M., Collins P. D., Scott D. M., Barnes P. J., Differences in interleukin-8 and tumor necrosis factor- α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. American Journal of Respiratory and Critical Care Medicine 1996 153 2 530 534 2-s2.0-0030071687
117. Mueller R., Chanez P., Campbell A. M., Bousquet J., Heusser C., Bullock G. R., Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. Respiratory Medicine 1996 90 2 79 85 2-s2.0-0029970401 10.1016/S0954-6111(96)90202-4 (Pubitemid 26109101)
118. Daldegan M. B., Teixeira M. M., Talvani A., Concentration of CCL11, CXCL8 and TNF- α in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation. Brazilian Journal of Medical and Biological Research 2005 38 9 1359 1365 2-s2.0-24744435851 (Pubitemid 41288421)
119. Vuillemenot B. R., Rodriguez J. F., Hoyle G. W., Lymphoid tissue and emphysema in the lungs of transgenic mice inducibly expressing tumor necrosis factor- α American Journal of Respiratory Cell and Molecular Biology 2004 30 4 438 448 2-s2.0-1842504010 10.1165/rcmb.2003-0062OC (Pubitemid 38457177)
120. Couillin I., Vasseur V., Charron S., Gasse P., Tavernier M., Guillet J., Lagente V., Fick L., Jacobs M., Coelho F. R., Moser R., Ryffel B., IL-1R1/MyD88
121. Lappalainen U., Whitsett J. A., Wert S. E., Tichelaar J. W., Bry K., Interleukin-1 β causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. American Journal of Respiratory Cell and Molecular Biology 2005 32 4 311 318 2-s2.0-16444377075 10.1165/rcmb.2004-0309OC (Pubitemid 40478306)
122. Fujisawa T., Velichko S., Thai P., Hung L. Y., Huang F., Wu R., Regulation of airway MUC5AC expression by IL-1 β and IL-17A; the NF- B paradigm. The Journal of Immunology 2009 183 10 6236 6243 2-s2.0-77954239363 10.4049/jimmunol.0900614
123. Wang Z., Zheng T., Zhu Z., Homer R. J., Riese R. J., Chapman H. A., Shapiro S. D., Elias J. A., Interferon γ induction of pulmonary emphysema in the adult murine lung. The Journal of Experimental Medicine 2000 192 11 1587 1600 10.1084/jem.192.11.1587
124. Churg A., Wang R. D., Tai H., Wang X., Xie C., Wright J. L., Tumor necrosis factor- α drives 70% of cigarette smoke-induced emphysema in the mouse. American Journal of Respiratory and Critical Care Medicine 2004 170 5 492 498 2-s2.0-4444322565 10.1164/rccm.200404-511OC (Pubitemid 39209129)
125. Fujita M., Shannon J. M., Irvin C. G., Fagan K. A., Cool C., Augustin A., Mason R. J., Overexpression of tumor necrosis factor- α produces an increase in lung volumes and pulmonary hypertension. American Journal of Physiology 2001 280 1 L39 L49 2-s2.0-0034997949
126. Thomson E. M., Williams A., Yauk C. L., Vincent R., Overexpression of tumor necrosis factor- α in the lungs alters immune response, matrix remodeling, and repair and maintenance pathways. The American Journal of Pathology 2012 180 4 1413 1430 10.1016/j.ajpath.2011.12.020
127. Matera M. G., Calzetta L., Cazzola M., TNF- α inhibitors in asthma and COPD: we must not throw the baby out with the bath water. Pulmonary Pharmacology and Therapeutics 2010 23 2 121 128 2-s2.0-75749095929 10.1016/j.pupt.2009.10.007
128. +ve cells in the lungs of smokers with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1999 160 2 711 717 2-s2.0-0032798485 (Pubitemid 29380694)
129. + T lymphocytes with FEV1. American Journal of Respiratory and Critical Care Medicine 1997 155 3 852 857 2-s2.0-0030900606 (Pubitemid 27133393)
130. Russell R. E. K., Culpitt S. V., DeMatos C., Donnelly L., Smith M., Wiggins J., Barnes P. J., Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology 2002 26 5 602 609 2-s2.0-0036010527 (Pubitemid 34315869)
131. Foronjy R., Nkyimbeng T., Wallace A., Thankachen J., Okada Y., Lemaitre V., D'Armiento J., Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. American Journal of Physiology 2008 294 6 L1149 L1157 2-s2.0-48949119331 10.1152/ajplung.00481.2007
132. Hurst J. R., Vestbo J., Anzueto A., Locantore N., Müllerova H., Tal-Singer R., Miller B., Lomas D. A., Agusti A., MacNee W., Calverley P., Rennard S., Wouters E. F. M., Wedzicha J. A., Susceptibility to exacerbation in chronic obstructive pulmonary disease. The New England Journal of Medicine 2010 363 12 1128 1138 2-s2.0-77956689733 10.1056/NEJMoa0909883
133. Taylor A. E., Finney-Hayward T. K., Quint J. K., Thomas C. M. R., Tudhope S. J., Wedzicha J. A., Barnes P. J., Donnelly L. E., Defective macrophage phagocytosis of bacteria in COPD. European Respiratory Journal 2010 35 5 1039 1047 2-s2.0-77951962615 10.1183/09031936.00036709
134. Prieto A., Reyes E., Bernstein E. D., Martinez B., Monserrat J., Izquierdo J. L., Callol L., De Lucas P., Alvarez-Sala R., Alvarez-Sala J. L., Villarrubia V. G., Alvarez-Mon M., Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferón). American Journal of Respiratory and Critical Care Medicine 2001 163 7 1578 1583 2-s2.0-0034948629 (Pubitemid 32578759)
135. Berenson C. S., Garlipp M. A., Grove L. J., Maloney J., Sethi S., Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. Journal of Infectious Diseases 2006 194 10 1375 1384 2-s2.0-33750718850 10.1086/508428 (Pubitemid 44706505)
136. Hodge S., Hodge G., Scicchitano R., Reynolds P. N., Holmes M., Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunology and Cell Biology 2003 81 4 289 296 2-s2.0-0041346077 10.1046/j.1440-1711.2003.t01-1-01170.x (Pubitemid 36904336)
137. Hodge S., Hodge G., Jersmann H., Matthews G., Ahern J., Holmes M., Reynolds P. N., Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2008 178 2 139 148 2-s2.0-46849097573 10.1164/rccm.200711-1666OC (Pubitemid 351957772)
138. Zheng T., Zhu Z., Wang Z., Homer R. J., Ma B., Riese R. J., Chapman H. A., Shapiro S. D., Elias J. A., Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. Journal of Clinical Investigation 2000 106 9 1081 1093 2-s2.0-0033761127
139. Raes G., De Baetselier P., Noël W., Beschin A., Brombacher F., Gholamreza H. G., Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. Journal of Leukocyte Biology 2002 71 4 597 602 2-s2.0-0036553909
140. Kzhyshkowska J., Mamidi S., Gratchev A., Kremmer E., Schmuttermaier C., Krusell L., Haus G., Utikal J., Schledzewski K., Scholtze J., Goerdt S., Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 2006 107 8 3221 3228 2-s2.0-33645727755 10.1182/blood-2005-07-2843
141. Létuvé S., Kozhich A., Humbles A., Brewah Y., Dombret M. C., Grandsaigne M., Adle H., Kolbeck R., Aubier M., Coyle A. J., Pretolani M., Lung chitinolytic activity and chitotriosidase are elevated in chronic obstructive pulmonary disease and contribute to lung inflammation. American Journal of Pathology 2010 176 2 638 649 2-s2.0-76149109158 10.2353/ajpath.2010. 090455
142. Agapov E., Battaile J. T., Tidwell R., Hachem R., Patterson G. A., Pierce R. A., Atkinson J. J., Holtzman M. J., Macrophage chitinase 1 stratifies chronic obstructive lung disease. American Journal of Respiratory Cell and Molecular Biology 2009 41 4 379 384 2-s2.0-70349140967 10.1165/2009-0122RC
143. Matsuura H., Hartl D., Kang M. J., Dela Cruz C. S., Koller B., Chupp G. L., Homer R. J., Zhou Y., Cho W. K., Elias J. A., Lee C. G., Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema. American Journal of Respiratory Cell and Molecular Biology 2011 44 6 777 786 10.1165/rcmb.2010-0081OC
144. Sakazaki Y., Hoshino T., Takei S., Sawada M., Oda H., Takenaka S., Imaoka H., Matsunaga K., Ota T., Abe Y., Miki I., Fujimoto K., Kawayama T., Kato S., Aizawa H., Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD. PLoS ONE 2011 6 10.1371/journal.pone. 0024177 e24177
145. Létuvé S., Kozhich A., Arouche N., Grandsaigne M., Reed J., Dombret M. C., Kiener P. A., Aubier M., Coyle A. J., Pretolani M., YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. The Journal of Immunology 2008 181 7 5167 5173 2-s2.0-58149308830
146. Kahnert A., Seiler P., Stein M., Bandermann S., Hahnke K., Mollenkopf H., Kaufmann S. H. E., Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. European Journal of Immunology 2006 36 3 631 647 2-s2.0-33644940526 10.1002/eji.200535496
147. Woodruff P. G., Koth L. L., Yang Y. H., Rodriguez M. W., Favoreto S., Dolganov G. M., Paquet A. C., Erle D. J., A distinctive alveolar macrophage activation state induced by cigarette smoking. American Journal of Respiratory and Critical Care Medicine 2005 172 11 1383 1392 2-s2.0-30344464994 10.1164/rccm.200505-686OC (Pubitemid 43069811)
148. Churg A., Wang R. D., Tai H., Wang X., Xie C., Dai J., Shapiro S. D., Wright J. L., Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor- α release. American Journal of Respiratory and Critical Care Medicine 2003 167 8 1083 1089 2-s2.0-0037447184 10.1164/rccm.200212-1396OC (Pubitemid 36459653)
149. Montaño M., Beccerril C., Ruiz V., Ramos C., Sansores R. H., González-Avila G., Matrix metalloproteinases activity in COPD associated with wood smoke. Chest 2004 125 2 466 472 2-s2.0-1242284331 10.1378/chest.125.2. 466 (Pubitemid 38223625)
150. Valença S. S., da Hora K., Castro P., Moraes V. G., Carvalho L., de Moraes Sobrino Porto L. C., Emphysema and metalloelastase expression in mouse lung induced by cigarette smoke. Toxicologic Pathology 2004 32 3 351 356 2-s2.0-2542468645 10.1080/01926230490431466 (Pubitemid 38692007)
151. Bracke K., Cataldo D., Maes T., Gueders M., Noël A., Foidart J. M., Brusselle G., Pauwels R. A., Matrix metalloproteinase-12 and Cathepsin D expression in pulmonary macrophages and dendritic cells of cigarette smoke-exposed mice. International Archives of Allergy and Immunology 2005 138 2 169 179 2-s2.0-27544503143 10.1159/000088439 (Pubitemid 41540674)
152. da Hora K., Valença S. S., Porto L. C., Immunohistochemical study of tumor necrosis factor- α matrix metalloproteinase-12, and tissue inhibitor of metalloproteinase-2 on alveolar macrophages of BALB/c mice exposed to short-term cigarette smoke. Experimental Lung Research 2005 31 8 759 770 2-s2.0-29244490096 10.1080/01902140500324828 (Pubitemid 41831704)
153. Churg A., Wang X., Wang R. D., Meixner S. C., Pryzdial E. L. G., Wright J. L., α 1-Antitrypsin suppresses TNF- α and MMP-12 production by cigarette smoke-stimulated macrophages. American Journal of Respiratory Cell and Molecular Biology 2007 37 2 144 151 2-s2.0-34547902512 10.1165/rcmb.2006-0345OC (Pubitemid 47254997)
154. Babusyte A., Stravinskaite K., Jeroch J., Lötvall J., Sakalauskas R., Sitkauskiene B., Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD. Respiratory Research 2007 8, article 81 2-s2.0-38549135676 10.1186/1465-9921-8-81
155. + CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 2008 112 8 3455 3464 2-s2.0-54049106148 10.1182/blood-2007-12- 129080
156. Hackett T. L., Holloway R., Holgate S. T., Warner J. A., Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study. Respiratory Research 2008 9, article 47 2-s2.0-47549119669 10.1186/1465-9921-9- 47
157. Takanashi S., Hasegawa Y., Kanehira Y., Yamamoto K., Fujimoto K., Satoh K., Okamura K., Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. European Respiratory Journal 1999 14 2 309 314 2-s2.0-0032847464 (Pubitemid 29461294)
158. Wallace W. A. H., Fitch P. M., Simpson A. J., Howie S. E. M., Inflammation-associated remodelling and fibrosis in the lung: a process and an end point. International Journal of Experimental Pathology 2007 88 2 103 110 2-s2.0-34147157791 10.1111/j.1365-2613.2006.00515.x (Pubitemid 46570076)
159. du Bois R. M., Strategies for treating idiopathic pulmonary fibrosis. Nature Reviews Drug Discovery 2010 9 2 129 140 2-s2.0-75949130829 10.1038/nrd2958
160. Raghu G., Weycker D., Edelsberg J., Bradford W. Z., Oster G., Incidence and prevalence of idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2006 174 7 810 816 2-s2.0-33749444308 10.1164/rccm.200602-163OC (Pubitemid 44511663)
161. Navaratnam V., Ali N., Smith C. J. P., McKeever T., Fogarty A., Hubbard R. B., Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis? Respiratory Medicine 2011 105 12 1925 1930 10.1016/j.rmed.2011.08.015
162. Perrio M. J., Ewen D., Trevethick M. A., Salmon G. P., Shute J. K., Fibrin formation by wounded bronchial epithelial cell layers in vitro is essential for normal epithelial repair and independent of plasma proteins. Clinical & Experimental Allergy 2007 37 11 1688 1700 2-s2.0-35348965151 10.1111/j.1365-2222.2007.02829.x (Pubitemid 47609854)
163. Bhandary Y. P., Shetty S. K., Marudamuthu A. S., Gyetko M. R., Idell S., Gharaee-Kermani M., Shetty R. S., Starcher B. C., Shetty S., Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system. American Journal of Physiology 2012 302 5 L463 L473 10.1152/ajplung.00099.2011
164. Eitzman D. T., McCoy R. D., Zheng X., Fay W. P., Shen T., Ginsburg D., Simon R. H., Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. Journal of Clinical Investigation 1996 97 1 232 237 2-s2.0-0030054203 (Pubitemid 26021713)
165. Kotani I., Sato A., Hayakawa H., Urano T., Takada Y., Takada A., Increased procoagulant and antifibrinolytic actvities in the lungs with idiopathic pulmonary fibrosis. Thrombosis Research 1995 77 6 493 504 2-s2.0-0028929665 10.1016/0049-3848(95)00025-9
166. Rossol M., Heine H., Meusch U., Quandt D., Klein C., Sweet M. J., Hauschildt S., LPS-induced cytokine production in human monocytes and macrophages. Critical Reviews in Immunology 2011 31 5 379 446
167. Stricter R. M., Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel. Chest 2005 128 5 526S 532S 2-s2.0-28044447391 10.1378/chest.128.5-suppl-1.526S (Pubitemid 41692558)
168. Selman M., Pardo A., Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proceedings of the American Thoracic Society 2006 3 4 364 372 2-s2.0-33744924735 10.1513/pats.200601-003TK (Pubitemid 43845414)
169. Wynn T. A., Ramalingam T. R., Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature Medicine 2012 18 7 1028 1040 10.1038/nm.2807
170. Richeldi L., Davies H. R., Ferrara G., Franco F., Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database of Systematic Reviews 2003 3 CD002880 2-s2.0-0141501440
171. Selman M., King T. E., Pardo A., Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Annals of Internal Medicine 2001 134 2 136 151 2-s2.0-0035895243 (Pubitemid 32096342)
172. Kang H. R., Soo J. C., Chun G. L., Homer R. J., Elias J. A., Transforming growth factor (TGF)- β 1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, Bid-activated pathway that involves matrix metalloproteinase-12. The Journal of Biological Chemistry 2007 282 10 7723 7732 2-s2.0-34147099468 10.1074/jbc.M610764200 (Pubitemid 47093708)
173. Krein P. M., Winston B. W., Roles for insulin-like growth factor I and transforming growth factor- β in fibrotic lung disease. Chest 2002 122 6 2-s2.0-0036936550
174. Bartram U., Speer C. P., The role of transforming growth factor β in lung development and disease. Chest 2004 125 2 754 765 2-s2.0-1242306647 10.1378/chest.125.2.754 (Pubitemid 38223659)
175. Vandenbroucke R. E., Dejonckheere E., Libert C., A therapeutic role for matrix metalloproteinase inhibitors in lung diseases? European Respiratory Journal 2011 38 5 1200 1214 10.1183/09031936.00027411
176. Selman M., Ruiz V., Cabrera S., Segura L., Ramírez R., Barrios R., Pardo A., TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? American Journal of Physiology 2000 279 3 L562 L574 2-s2.0-0033830350
177. Nagai T., Tanaka M., Hasui K., Shirahama H., Kitajima S., Yonezawa S., Xu B., Matsuyama T., Effect of an immunotoxin to folate receptor on bleomycin-induced experimental pulmonary fibrosis. Clinical and Experimental Immunology 2010 161 2 348 356 2-s2.0-77954636757 10.1111/j.1365-2249.2010.04182. x
178. Xia W., Hilgenbrink A. R., Matteson E. L., Lockwood M. B., Cheng J. X., Low P. S., A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 2009 113 2 438 446 2-s2.0-58849142161 10.1182/blood-2008-04-150789
179. Herold S., Mayer K., Lohmeyer J., Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Frontiers in Immunology 2011 2 65 10.3389/fimmu.2011.00065
180. Barlo N. P., van Moorsel C. H. M., Korthagen N. M., Heron M., Rijkers G. T., Ruven H. J. T., van den Bosch J. M. M., Grutters J. C., Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1 β in idiopathic pulmonary fibrosis. Clinical & Experimental Immunology 2011 166 3 346 351 10.1111/j.1365-2249.2011.04468.x
181. Brass D. M., Spencer J. C., Li Z., Potts-Kant E., Reilly S. M., Dunkel M. K., Latoche J. D., Auten R. L., Hollingsworth J. W., Fattman C. L., Innate immune activation by inhaled lipopolysaccharide, independent of oxidative stress, exacerbates silica-induced pulmonary fibrosis in mice. PLoS ONE 2012 7 7 10.1371/journal.pone.0040789 e40789
182. Wilson M. S., Madala S. K., Ramalingam T. R., Gochuico B. R., Rosas I. O., Cheever A. W., Wynn T. A., Bleomycin and IL-1 β -mediated pulmonary fibrosis is IL-17A dependent. Journal of Experimental Medicine 2010 207 3 535 552 2-s2.0-77949516122 10.1084/jem.20092121
183. Zhang Y., Lee T. C., Guillemin B., Yu M. C., Rom W. N., Enhanced IL-1 β and tumor necrosis factor- α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. The Journal of Immunology 1993 150 9 4188 4196 2-s2.0-0027212844 (Pubitemid 23129800)
184. Ziegenhagen M. W., Schrum S., Zissel G., Zipfel P. F., Schlaak M., Müller-Quernheim J., Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. Journal of Investigative Medicine 1998 46 5 223 231 2-s2.0-0032084906 (Pubitemid 128452762)
185. Strausz J., Muller-Quernheim J., Steppling H., Ferlinz R., Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. American Review of Respiratory Disease 1990 141 1 124 128 2-s2.0-0025019279 (Pubitemid 20023394)
186. Kiemle-Kallee J., Kreipe H., Radzun H. J., Parwaresch M. R., Auerswald U., Magnussen H., Barth J., Alveolar macrophages in idiopathic pulmonary fibrosis display a more monocyte-like immunophenotype and an increased release of free oxygen radicals. European Respiratory Journal 1991 4 4 400 406 2-s2.0-0025727883
187. Schaberg T., Rau M., Stephan H., Lode H., Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells. American Review of Respiratory Disease 1993 147 6 1507 1513 2-s2.0-0027207935 (Pubitemid 23160554)
188. Kline J. N., Schwartz D. A., Monick M. M., Floerchinger C. S., Hunninghake G. W., Relative release of interleukin-1 β and interleukin-1 receptor antagonist by alveolar macrophages: a study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis. Chest 1993 104 1 47 53 2-s2.0-0027164553 (Pubitemid 23204527)
189. Gibbons M. A., MacKinnon A. C., Ramachandran P., Dhaliwal K., Duffin R., Phythian-Adams A. T., van Rooijen N., Haslett C., Howie S. E., Simpson A. J., Hirani N., Gauldie J., Iredale J. P., Sethi T., Forbes S. J., Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. American Journal of Respiratory and Critical Care Medicine 2011 184 5 569 581 10.1164/rccm.201010-1719OC
190. Cakarova L., Marsh L. M., Wilhelm J., Mayer K., Grimminger F., Seeger W., Lohmeyer J., Herold S., Macrophage tumor necrosis factor- α induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair. American Journal of Respiratory and Critical Care Medicine 2009 180 6 521 532 2-s2.0-69949097543 10.1164/rccm.200812-1837OC
191. Duffield J. S., Forbes S. J., Constandinou C. M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., Iredale J. P., Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. Journal of Clinical Investigation 2005 115 1 56 65 2-s2.0-13744255589 10.1172/JCI200522675 (Pubitemid 40385505)
192. Henry M. T., McMahon K., Mackarel A. J., Prikk K., Sorsa T., Maisi P., Sepper R., FitzGerald M. X., O'Connor C. M., Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. European Respiratory Journal 2002 20 5 1220 1227 2-s2.0-0036848469 10.1183/09031936.02. 00022302 (Pubitemid 35331881)
193. Lemjabbar H., Gosset P., Lechapt-Zalcman E., Franco-Montoya M. L., Wallaert B., Harf A., Lafuma C., Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis effects of steroid and immunosuppressive treatment. American Journal of Respiratory Cell and Molecular Biology 1999 20 5 903 913 2-s2.0-0033126693 (Pubitemid 129540849)
194. Beeh K. M., Beier J., Kornmann O., Buhl R., Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respiratory Medicine 2003 97 6 634 639 2-s2.0-0037637437 10.1053/rmed.2003.1493 (Pubitemid 36675664)
195. Jakubzick C., Kunkel S. L., Puri R. K., Hogaboam C. M., Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis. Immunologic Research 2004 30 3 339 349 2-s2.0-9144234160 10.1385/IR:30:3:339 (Pubitemid 39546234)
196. Chiaramonte M. G., Schopf L. R., Neben T. Y., Cheever A. W., Donaldson D. D., Wynn T. A., IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. The Journal of Immunology 1999 162 2 920 930 2-s2.0-0033555809 (Pubitemid 29035417)
197. Kumar R. K., Herbert C., Yang M., Koskinen A. M. L., McKenzie A. N. J., Foster P. S., Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clinical & Experimental Allergy 2002 32 7 1104 1111 2-s2.0-0035987319 10.1046/j.1365-2222.2002.01420.x (Pubitemid 34779610)
198. Ramalingam T. R., Pesce J. T., Sheikh F., Cheever A. W., Mentink-Kane M. M., Wilson M. S., Stevens S., Valenzuela D. M., Murphy A. J., Yancopoulos G. D., Urban J. F., Donnelly R. P., Wynn T. A., Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor α 1 chain. Nature Immunology 2008 9 1 25 33 2-s2.0-37349073223 10.1038/ni1544 (Pubitemid 350286200)
199. Lama V. N., Harada H., Badri L. N., Flint A., Hogaboam C. M., McKenzie A., Martinez F. J., Toews G. B., Moore B. B., Pinsky D. J., Obligatory role for interleukin-13 in obstructive lesion development in airway allografts. American Journal of Pathology 2006 169 1 47 60 2-s2.0-33745714813 10.2353/ajpath.2006. 050975
200. Keane M. P., Gomperts B. N., Weigt S., Xue Y. Y., Burdick M. D., Nakamura H., Zisman D. A., Ardehali A., Saggar R., Lynch J. P., Hogaboam C., Kunkel S. L., Lukacs N. W., Ross D. J., Grusby M. J., Strieter R. M., Belperio J. A., IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome. The Journal of Immunology 2007 178 1 511 519 2-s2.0-33845922119 (Pubitemid 46033635)
201. Kolodsick J. E., Toews G. B., Jakubzick C., Hogaboam C., Moore T. A., McKenzie A., Wilke C. A., Chrisman C. J., Moore B. B., Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. The Journal of Immunology 2004 172 7 4068 4076 2-s2.0-1642333177 (Pubitemid 38375218)
202. Yang G., Volk A., Petley T., Emmell E., Giles-Komar J., Shang X., Li J., Das A. M., Shealy D., Griswold D. E., Li L., Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 2004 28 6 224 232 2-s2.0-9644276704 10.1016/j.cyto.2004.08.007 (Pubitemid 39573497)
203. Hancock A., Armstrong L., Gama R., Millar A., Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. American Journal of Respiratory Cell and Molecular Biology 1998 18 1 60 65 2-s2.0-0031606459 (Pubitemid 128355347)
204. Pechkovsky D. V., Prasse A., Kollert F., Engel K. M. Y., Dentler J., Luttmann W., Friedrich K., Müller-Quernheim J., Zissel G., Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clinical Immunology 2010 137 1 89 101 2-s2.0-77956618333 10.1016/j.clim.2010.06.017
205. Uh S. T., Inoue Y., King T. E., Chan E. D., Newman L. S., Riches D. W. H., Morphometric analysis of insulin-like growth factor-1 localization in lung tissues of patients with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 1998 158 5 1626 1635 2-s2.0-0031762979
206. Vignaud J. M., Allam M., Martinet N., Pech M., Plenat F., Martinet Y., Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene. American journal of respiratory cell and molecular biology 1991 5 6 531 538 2-s2.0-0026279912
207. Chen F., Liu Z., Wu W., Rozo C., Bowdridge S., Millman A., Van Rooijen N., Urban J. F. Jr., Wynn T. A., Gause W. C., An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nature Medicine 2012 18 2 260 266 10.1038/nm.2628
208. MacKinnon A. C., Farnworth S. L., Hodkinson P. S., Henderson N. C., Atkinson K. M., Leffler H., Nilsson U. J., Haslett C., Forbes S. J., Sethi T., Regulation of alternative macrophage activation by galectin-3. The Journal of Immunology 2008 180 4 2650 2658 2-s2.0-42149161735
209. Nishi Y., Sano H., Kawashima T., Okada T., Kuroda T., Kikkawa K., Kawashima S., Tanabe M., Goto T., Matsuzawa Y., Matsumura R., Tomioka H., Liu F. T., Shirai K., Role of galectin-3 in human pulmonary fibrosis. Allergology International 2007 56 1 57 65 2-s2.0-33947417260 10.2332/allergolint.O-06-449 (Pubitemid 46449664)
210. Prasse A., Pechkovsky D. V., Toews G. B., Jungraithmayr W., Kollert F., Goldmann T., Vollmer E., Müller-Quernheim J., Zissel G., A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. American Journal of Respiratory and Critical Care Medicine 2006 173 7 781 792 2-s2.0-33645307685 10.1164/rccm.200509-1518OC
211. Furuhashi K., Suda T., Nakamura Y., Inui N., Hashimoto D., Miwa S., Hayakawa H., Kusagaya H., Nakano Y., Nakamura H., Chida K., Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis. Respiratory Medicine 2010 104 8 1204 1210 2-s2.0-77953916068 10.1016/j.rmed.2010.02.026
212. Mora A. L., Torres-González E., Rojas M., Corredor C., Ritzenthaler J., Xu J., Roman J., Brigham K., Stecenko A., Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. American Journal of Respiratory Cell and Molecular Biology 2006 35 4 466 473 2-s2.0-33749173797 10.1165/rcmb.2006-0121OC (Pubitemid 44477646)
213. Mathai S. K., Gulati M., Peng X., Russell T. R., Shaw A. C., Rubinowitz A. N., Murray L. A., Siner J. M., Antin-Ozerkis D. E., Montgomery R. R., Reilkoff R. A., Bucala R. J., Herzog E. L., Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Laboratory Investigation 2010 90 6 812 823 2-s2.0-77954602335 10.1038/labinvest.2010.73
214. Matute-Bello G., Wurfel M. M., Lee J. S., Park D. R., Frevert C. W., Madtes D. K., Shapiro S. D., Martin T. R., Essential role of MMP-12 in fas-induced lung fibrosis. American Journal of Respiratory Cell and Molecular Biology 2007 37 2 210 221 2-s2.0-34547897710 10.1165/rcmb.2006-0471OC (Pubitemid 47255004)
215. Madala S. K., Pesce J. T., Ramalingam T. R., Wilson M. S., Minnicozzi S., Cheever A. W., Thompson R. W., Mentink-Kane M. M., Wynn T. A., Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis. The Journal of Immunology 2010 184 7 3955 3963 2-s2.0-77951627980 10.4049/jimmunol.0903008
216. Liu T., Dhanasekaran S. M., Jin H., Hu B., Tomlins S. A., Chinnaiyan A. M., Phan S. H., FIZZ1 stimulation of myofibroblast differentiation. American Journal of Pathology 2004 164 4 1315 1326 2-s2.0-1642357498 (Pubitemid 38387797)
217. Pesce J. T., Ramalingam T. R., Mentink-Kane M. M., Wilson M. S., Kasmi K. C. E., Smith A. M., Thompson R. W., Cheever A. W., Murray P. J., Wynn T. A., Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathogens 2009 5 4 e1000371 2-s2.0-66349084135 10.1371/journal.ppat.1000371
218. Herbert D. R., Hölscher C., Mohrs M., Arendse B., Schwegmann A., Radwanska M., Leeto M., Kirsch R., Hall P., Mossmann H., Claussen B., Förster I., Brombacher F., Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004 20 5 623 635 2-s2.0-2442717844 10.1016/S1074-7613(04)00107-4 (Pubitemid 38659504)
219. Atabai K., Jame S., Azhar N., Kuo A., Lam M., McKleroy W., DeHart G., Rahman S., Xia D. D., Melton A. C., Wolters P., Emson C. L., Turner S. M., Werb Z., Sheppard D., Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages. Journal of Clinical Investigation 2009 119 12 3713 3722 2-s2.0-72849117761 10.1172/JCI40053
220. Lopez-Guisa J. M., Cai X., Collins S. J., Yamaguchi I., Okamura D. M., Bugge T. H., Isacke C. M., Emson C. L., Turner S. M., Shankland S. J., Eddy A. A., Mannose receptor 2 attenuates renal fibrosis. Journal of the American Society of Nephrology 2012 23 2 236 251 10.1681/ASN.2011030310
221. Tsoutsou P. G., Gourgoulianis K. I., Petinaki E., Germenis A., Tsoutsou A. G., Mpaka M., Efremidou S., Molyvdas P. A., Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis. Respiratory Medicine 2006 100 5 938 945
222. Freeburn R. W., Armstrong L., Millar A. B., Cultured alveolar macrophages from patients with idiopathic pulmonary fibrosis (IPF) show dysregulation of lipopolysaccharide-induced tumor necrosis factor- α (TNF- α) and interleukin-10 (IL-10) inductions. European Cytokine Network 2005 16 1 5 16 2-s2.0-16444365549 (Pubitemid 40478071)
223. Martinez J., Sanchez T., Moreno J. J., Role of prostaglandin H synthase-2-mediated conversion of arachidonic acid in controlling 3T6 fibroblast growth. American Journal of Physiology 1997 273 5 C1466 C1471 2-s2.0-0030716934
224. Armstrong L., Jordan N., Millar A., Interleukin 10 (IL-10) regulation of tumour necrosis factor α (TNF- α) from human alveolar macrophages and peripheral blood monocytes. Thorax 1996 51 2 143 149 2-s2.0-0030064864
225. Kradin R. L., Sakamoto H., Jain F., Zhao L. H., Hymowitz G., Preffer F., IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin. Experimental and Molecular Pathology 2004 76 3 205 211 2-s2.0-2342564524 10.1016/j.yexmp.2003.12.010 (Pubitemid 38569781)
226. Nakagome K., Dohi M., Okunishi K., Tanaka R., Miyazaki J., Yamamoto K., In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF- β in the lung. Thorax 2006 61 10 886 894 2-s2.0-33750017364 10.1136/thx.2005.056317 (Pubitemid 44570310)
227. Sun L., Louie M. C., Vannella K. M., Wilke C. A., Levine A. M., Moore B. B., Shanley T. P., New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. American Journal of Physiology 2011 300 3 L341 L353 2-s2.0-79955005448 10.1152/ajplung.00122.2010
228. Melgert B. N., Olinga P., Jack V. K., Molema G., Meijer D. K. F., Poelstra K., Dexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cells. Journal of Hepatology 2000 32 4 603 611 2-s2.0-0034068404 10.1016/S0168-8278(00)80222-6 (Pubitemid 30180380)